Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-062117
Filing Date
2023-03-07
Accepted
2023-03-07 07:42:38
Documents
5
Effectiveness Date
2023-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d465067ds8.htm S-8 49387
2 EX-5.1 d465067dex51.htm EX-5.1 12130
3 EX-23.1 d465067dex231.htm EX-23.1 1659
4 EX-FILING FEES d465067dexfilingfees.htm EX-FILING FEES 19928
5 GRAPHIC g465067g0302050731582.jpg GRAPHIC 1785
  Complete submission text file 0001193125-23-062117.txt   86783
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270319 | Film No.: 23711052
SIC: 2834 Pharmaceutical Preparations